Johnson & Johnson logo

Johnson & Johnson

NEW
NYSE:JNJ (USA)   Ordinary Shares
$ 250.61 +1.79 (+0.72%) 04:00 PM EST
29.04
P/B:
7.43
Market Cap:
$ 603.27B
Enterprise V:
$ 636.21B
Volume:
6.89M
Avg Vol (2M):
8.39M
Trade In:
Volume:
6.89M
Avg Vol (2M):
8.39M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PS Ratio for Johnson & Johnson ( ) from 1990 to Jul 21 2026. The price to sales ratio is calculated by taking the current stock price and dividing it by the trailing twelve-month sales per share. The data is updated every 20 minutes during market hours. The PS ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS ratio is a great valuation tool for evaluating cyclical businesses where the PE ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean. Johnson & Johnson stock (JNJ) PS ratio as of Jul 21 2026 is 6.27. More Details

Johnson & Johnson (JNJ) PS Ratio Chart

To

Johnson & Johnson (JNJ) PS Ratio Historical Data

Total 1207
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Johnson & Johnson PS Ratio Historical Data
Date PS Ratio Data Date PS Ratio Data
2026-07-21 6.2 6.26 6.12 6.24 2026-05-14 5.8 5.85 5.79 5.83
2026-07-20 6.3 6.33 6.19 6.2 2026-05-13 5.7 5.83 5.69 5.82
2026-07-17 6.3 6.37 6.28 6.3 2026-05-12 5.6 5.75 5.6 5.66
2026-07-16 6.2 6.32 6.14 6.23 2026-05-11 5.6 5.64 5.57 5.59
2026-07-15 6.2 6.4 6.13 6.15 2026-05-08 5.6 5.64 5.58 5.59
2026-07-14 6.4 6.39 6.28 6.32 2026-05-07 5.7 5.68 5.57 5.62
2026-07-13 6.4 6.47 6.38 6.42 2026-05-06 5.7 5.72 5.63 5.67
2026-07-10 6.5 6.51 6.37 6.4 2026-05-05 5.7 5.72 5.68 5.7
2026-07-09 6.5 6.56 6.43 6.45 2026-05-04 5.7 5.74 5.65 5.66
2026-07-08 6.7 6.69 6.56 6.56 2026-05-01 5.8 5.8 5.73 5.74
2026-07-07 6.6 6.71 6.58 6.66 2026-04-30 5.8 5.84 5.75 5.81
2026-07-06 6.5 6.51 6.38 6.46 2026-04-29 5.7 5.78 5.68 5.74
2026-07-02 6.4 6.55 6.33 6.55 2026-04-28 5.8 5.84 5.72 5.75
2026-07-01 6.3 6.33 6.25 6.33 2026-04-27 5.7 5.76 5.67 5.69
2026-06-30 6.5 6.47 6.31 6.33 2026-04-24 5.8 5.81 5.73 5.75
2026-06-29 6.3 6.44 6.28 6.44 2026-04-23 5.7 5.84 5.73 5.83
2026-06-26 6.3 6.44 6.26 6.43 2026-04-22 5.7 5.75 5.65 5.71
2026-06-25 6.1 6.27 6.08 6.19 2026-04-21 5.8 5.8 5.68 5.71
2026-06-24 6.1 6.14 6.03 6.09 2026-04-20 5.9 5.94 5.8 5.83
2026-06-23 6.0 6.06 5.92 6.04 2026-04-17 5.9 5.95 5.86 5.92
2026-06-22 5.8 5.85 5.75 5.84 2026-04-16 6.0 6.02 5.86 5.92
2026-06-18 5.8 5.88 5.75 5.77 2026-04-15 6.1 6.07 5.98 6.03
2026-06-17 5.9 5.95 5.83 5.92 2026-04-14 5.9 6.12 5.89 6.06
2026-06-16 6.0 5.97 5.84 5.94 2026-04-13 6.0 6.02 5.94 6.01
2026-06-15 6.0 6.05 5.9 5.95 2026-04-10 6.1 6.12 6.01 6.02
2026-06-12 6.1 6.09 6 6.08 2026-04-09 6.1 6.17 6.08 6.1
2026-06-11 6.1 6.1 6.02 6.02 2026-04-08 6.0 6.1 5.91 6.09
2026-06-10 6.0 6.09 5.99 6.02 2026-04-07 6.1 6.08 5.96 6.02
2026-06-09 5.9 6 5.82 5.99 2026-04-06 6.1 6.15 6.07 6.09
2026-06-08 5.9 5.93 5.82 5.86 2026-04-02 6.2 6.24 6.11 6.14
2026-06-05 5.8 5.94 5.78 5.88 2026-04-01 6.2 6.24 6.16 6.17
2026-06-04 5.7 5.78 5.71 5.76 2026-03-31 6.2 6.2 6.13 6.17
2026-06-03 5.6 5.68 5.61 5.64 2026-03-30 6.2 6.17 6.08 6.13
2026-06-02 5.6 5.7 5.59 5.63 2026-03-27 6.2 6.26 6.17 6.2
2026-06-01 5.6 5.67 5.58 5.65 2026-03-26 6.2 6.23 6.16 6.17
2026-05-29 5.8 5.85 5.67 5.69 2026-03-25 6.1 6.23 6.08 6.19
2026-05-28 5.8 5.86 5.8 5.83 2026-03-24 6.0 6.09 5.99 6.07
2026-05-27 5.8 5.88 5.78 5.84 2026-03-23 6.1 6.15 6.04 6.07
2026-05-26 5.9 5.89 5.79 5.81 2026-03-20 6.1 6.14 6.05 6.07
2026-05-22 5.9 5.95 5.88 5.92 2026-03-19 6.1 6.17 6.09 6.13
2026-05-21 5.8 5.86 5.74 5.85 2026-03-18 6.1 6.17 6.07 6.12
2026-05-20 5.8 5.86 5.79 5.79 2026-03-17 6.3 6.3 6.12 6.14
2026-05-19 5.8 5.83 5.76 5.81 2026-03-16 6.3 6.32 6.23 6.27
2026-05-18 5.7 5.8 5.7 5.78 2026-03-13 6.3 6.33 6.23 6.23
2026-05-15 5.8 5.86 5.72 5.73 2026-03-12 6.2 6.3 6.2 6.24

Johnson & Johnson (JNJ) PS Ratio Comparison

Company Market Cap(Mil) PS Ratio

Business Description

Business Description

Description
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.